Talent acquisition leaders at leading pharma and biotech organizations are leveraging technologies, including automation, to ...

Acadia Pharmaceuticals was testing the drug, an intranasal formulation of the oxytocin analogue carbetocin, for its potential ...

Lilly expects to open 615 high-wage roles in Texas in connection with its new facility, plus around 4,000 construction roles.

The FDA is hoping to repurpose GSK’s Wellcovorin for cerebral folate deficiency; Pfizer acquired fast-moving weight-loss ...

The regulatory action marks the second rejection for a spinal muscular atrophy therapy this week after Scholar Rock’s ...

The FDA has issued a warning letter to Johnson & Johnson’s subsidiary Janssen Vaccines, flagging lapses in quality control and the failure to follow good manufacturing practices at a production plant ...

By improving gait stability, Ionis’ zilganersen could be “potentially disease modifying,” according to analysts at William ...

While last week’s recommended changes by CDC advisors to the MMRV vaccine schedule are unlikely to have a tangible effect on ...

The agency also pointed to the use of Tylenol and other acetaminophen products during pregnancy as being potentially linked ...

An advisory committee last year found that Zynquista’s benefit-risk profile in type 1 diabetes was unfavorable due to cases ...

In its rejection letter, the FDA flagged problems at a third-party fill-finish site owned by Novo Nordisk. Issues at this ...

Small and large drugmakers alike have made big, proactive moves to secure the production capacity that will be vital to ...